Madison Asset Management LLC acquired a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 23,786 shares of the company’s stock, valued at approximately $3,057,000.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Addison Advisors LLC acquired a new stake in Merck KGaA during the 2nd quarter worth $90,000. Comprehensive Financial Planning Inc. PA acquired a new position in shares of Merck KGaA in the 2nd quarter valued at $134,000. Stevens Capital Partners acquired a new position in shares of Merck KGaA in the 2nd quarter valued at $220,000. Kelman Lazarov Inc. bought a new position in shares of Merck KGaA in the 2nd quarter worth $448,000. Finally, BOK Financial Private Wealth Inc. bought a new position in shares of Merck KGaA in the 2nd quarter worth $523,000. 0.10% of the stock is owned by institutional investors.
Merck KGaA Stock Down 0.9%
Shares of Merck KGaA stock opened at $162.12 on Friday. The business has a fifty day simple moving average of $162.47 and a 200 day simple moving average of $148.35. The stock has a market cap of $20.95 billion, a PE ratio of 24.75 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. Merck KGaA has a 12 month low of $116.68 and a 12 month high of $175.56.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
